Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Black Diamond Therapeutics Inc (BDTX)

Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Black Diamond Therapeutics Inc ONE MAIN STREET 14TH FLOOR CAMBRIDGE MA 02142 USA

www. blackdiamondtherapeutics.com Employees: 54 P: 617-252-0848

Description:

Black Diamond Therapeutics Inc. is an oncology medicine company. It engages in discovery and development of small molecule, tumor-agnostic therapies. The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor and tyrosine-protein kinase. Black Diamond Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 168,950
Enterprise Value, $K 112,730
Shares Outstanding, K 56,505
Annual Sales, $ 0 K
Annual Net Income, $ -82,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -19,910 K
EBIT, $ -87,250 K
EBITDA, $ -86,810 K
60-Month Beta 2.51
% of Insider Shareholders 8.87%
% of Institutional Shareholders 95.47%
Float, K 51,493
% Float 91.13%
Short Volume Ratio 0.68

Growth:

1-Year Return 63.16%
3-Year Return -61.27%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 08/06/24
Next Earnings Date 11/04/24 [--]
Earnings Per Share ttm -1.50
EPS Growth vs. Prev Qtr -2.86%
EPS Growth vs. Prev Year 30.77%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BDTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -69.08%
Return-on-Assets % -51.68%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.46
Book Value/Share 1.97
Interest Coverage -2.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar